Evaluating Therapeutic Drug Monitoring in IBD

Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Adam S. Cheifetz, MD

Therapeutic drug monitoring has emerged as an important tool to optimize therapy for patients with inflammatory bowel disease (IBD). To help us learn more about this tool, Dr. Peter Buch is joined by Dr. Adam Cheifetz of Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School.